Neurosom announces oversubscribed bridge round financing as company advances towards Seed Round in 1H 2026
Eugene, January 6, 2026 — OR – Neurosom, the developer of a personalized, at-home neuromodulation therapy to improve deep and REM sleep, key factors in reducing dementia risk, today announced the imminent closing of an… Read More »Neurosom announces oversubscribed bridge round financing as company advances towards Seed Round in 1H 2026





